NOVARTIS AG;BETH ISRAEL DEACONESS MEDICAL CENTER INC.
发明人:
申请号：
IL26908319
公开号：
IL269083D0
申请日:
2019.09.02
申请国别(地区):
IL
年份:
2019
代理人:
摘要：
The disclosure relates to novel uses and methods for preventing and/or treating heart disease, which employ a therapeutically effective amount of an ActRII receptor antagonist, e.g., an ActRII receptor binding molecule, e.g., an ActRII receptor antibody, such as the bimagrumab antibody.
